
The global market for PTA Balloons for Peripheral Arterial Disease was valued at US$ 1029 million in the year 2024 and is projected to reach a revised size of US$ 1819 million by 2031, growing at a CAGR of 8.6% during the forecast period.
A PTA balloon catheter has an inflatable "balloon" at its tip which is used during a minimally invasive catheterization procedure. This procedure is intended to enlarge a narrowed vessel opening. The deflated balloon is positioned at the narrowed space, inflated for a short period of time, and deflated again to be removed.
The PTA Balloons for Peripheral Arterial Disease market is driven by the rising prevalence of peripheral arterial disease (PAD) and the need for effective minimally invasive treatment options. Percutaneous transluminal angioplasty (PTA) balloons are used to open narrowed or blocked arteries, restoring blood flow. The increase in PAD cases and the demand for procedures that avoid traditional surgical interventions contribute to market growth as patients and healthcare providers seek less invasive and quicker solutions. Moreover, advancements in balloon design and materials, including improved flexibility and enhanced inflation control, align with procedural success rates. However, the market also faces challenges, including addressing the potential for vessel damage during balloon inflation and managing patient suitability for PTA procedures. Additionally, gaining reimbursement approval and promoting awareness about PAD treatment options can pose obstacles for manufacturers. To succeed, companies must focus on technological innovation, collaborate with vascular specialists for procedural insights, and address the challenges to meet the increasing demand for effective and safe PTA balloon solutions for PAD patients.
Report Scope
This report aims to provide a comprehensive presentation of the global market for PTA Balloons for Peripheral Arterial Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PTA Balloons for Peripheral Arterial Disease.
The PTA Balloons for Peripheral Arterial Disease market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global PTA Balloons for Peripheral Arterial Disease market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the PTA Balloons for Peripheral Arterial Disease manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Medtronic
Boston Scientific
Abbott
COOK
Cardiovascular Systems
Terumo
B. Braun
Biotronik
Segment by Type
Cutting and Scoring Balloons
Drug-Coated Balloons
Segment by Application
Hospitals
ASCs
Catheterization Laboratory
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of PTA Balloons for Peripheral Arterial Disease manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of PTA Balloons for Peripheral Arterial Disease in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report. 
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 PTA Balloons for Peripheral Arterial Disease Âé¶¹Ô´´ Overview
1.1 Product Definition
1.2 PTA Balloons for Peripheral Arterial Disease by Type
1.2.1 Global PTA Balloons for Peripheral Arterial Disease Âé¶¹Ô´´ Value Comparison by Type (2024 VS 2031)
1.2.2 Cutting and Scoring Balloons
1.2.3 Drug-Coated Balloons
1.3 PTA Balloons for Peripheral Arterial Disease by Application
1.3.1 Global PTA Balloons for Peripheral Arterial Disease Âé¶¹Ô´´ Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 ASCs
1.3.4 Catheterization Laboratory
1.4 Global PTA Balloons for Peripheral Arterial Disease Âé¶¹Ô´´ Size Estimates and Forecasts
1.4.1 Global PTA Balloons for Peripheral Arterial Disease Revenue 2020-2031
1.4.2 Global PTA Balloons for Peripheral Arterial Disease Sales 2020-2031
1.4.3 Global PTA Balloons for Peripheral Arterial Disease Âé¶¹Ô´´ Average Price (2020-2031)
1.5 Assumptions and Limitations
2 PTA Balloons for Peripheral Arterial Disease Âé¶¹Ô´´ Competition by Manufacturers
2.1 Global PTA Balloons for Peripheral Arterial Disease Sales Âé¶¹Ô´´ Share by Manufacturers (2020-2025)
2.2 Global PTA Balloons for Peripheral Arterial Disease Revenue Âé¶¹Ô´´ Share by Manufacturers (2020-2025)
2.3 Global PTA Balloons for Peripheral Arterial Disease Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of PTA Balloons for Peripheral Arterial Disease, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of PTA Balloons for Peripheral Arterial Disease, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of PTA Balloons for Peripheral Arterial Disease, Product Type & Application
2.7 Global Key Manufacturers of PTA Balloons for Peripheral Arterial Disease, Date of Enter into This Industry
2.8 Global PTA Balloons for Peripheral Arterial Disease Âé¶¹Ô´´ Competitive Situation and Trends
2.8.1 Global PTA Balloons for Peripheral Arterial Disease Âé¶¹Ô´´ Concentration Rate
2.8.2 The Global 5 and 10 Largest PTA Balloons for Peripheral Arterial Disease Players Âé¶¹Ô´´ Share by Revenue
2.8.3 Global PTA Balloons for Peripheral Arterial Disease Âé¶¹Ô´´ Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global PTA Balloons for Peripheral Arterial Disease Âé¶¹Ô´´ Scenario by Region
3.1 Global PTA Balloons for Peripheral Arterial Disease Âé¶¹Ô´´ Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global PTA Balloons for Peripheral Arterial Disease Sales by Region: 2020-2031
3.2.1 Global PTA Balloons for Peripheral Arterial Disease Sales by Region: 2020-2025
3.2.2 Global PTA Balloons for Peripheral Arterial Disease Sales by Region: 2026-2031
3.3 Global PTA Balloons for Peripheral Arterial Disease Revenue by Region: 2020-2031
3.3.1 Global PTA Balloons for Peripheral Arterial Disease Revenue by Region: 2020-2025
3.3.2 Global PTA Balloons for Peripheral Arterial Disease Revenue by Region: 2026-2031
3.4 North America PTA Balloons for Peripheral Arterial Disease Âé¶¹Ô´´ Facts & Figures by Country
3.4.1 North America PTA Balloons for Peripheral Arterial Disease Âé¶¹Ô´´ Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America PTA Balloons for Peripheral Arterial Disease Sales by Country (2020-2031)
3.4.3 North America PTA Balloons for Peripheral Arterial Disease Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe PTA Balloons for Peripheral Arterial Disease Âé¶¹Ô´´ Facts & Figures by Country
3.5.1 Europe PTA Balloons for Peripheral Arterial Disease Âé¶¹Ô´´ Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe PTA Balloons for Peripheral Arterial Disease Sales by Country (2020-2031)
3.5.3 Europe PTA Balloons for Peripheral Arterial Disease Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific PTA Balloons for Peripheral Arterial Disease Âé¶¹Ô´´ Facts & Figures by Region
3.6.1 Asia Pacific PTA Balloons for Peripheral Arterial Disease Âé¶¹Ô´´ Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific PTA Balloons for Peripheral Arterial Disease Sales by Region (2020-2031)
3.6.3 Asia Pacific PTA Balloons for Peripheral Arterial Disease Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America PTA Balloons for Peripheral Arterial Disease Âé¶¹Ô´´ Facts & Figures by Country
3.7.1 Latin America PTA Balloons for Peripheral Arterial Disease Âé¶¹Ô´´ Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America PTA Balloons for Peripheral Arterial Disease Sales by Country (2020-2031)
3.7.3 Latin America PTA Balloons for Peripheral Arterial Disease Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa PTA Balloons for Peripheral Arterial Disease Âé¶¹Ô´´ Facts & Figures by Country
3.8.1 Middle East and Africa PTA Balloons for Peripheral Arterial Disease Âé¶¹Ô´´ Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa PTA Balloons for Peripheral Arterial Disease Sales by Country (2020-2031)
3.8.3 Middle East and Africa PTA Balloons for Peripheral Arterial Disease Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global PTA Balloons for Peripheral Arterial Disease Sales by Type (2020-2031)
4.1.1 Global PTA Balloons for Peripheral Arterial Disease Sales by Type (2020-2025)
4.1.2 Global PTA Balloons for Peripheral Arterial Disease Sales by Type (2026-2031)
4.1.3 Global PTA Balloons for Peripheral Arterial Disease Sales Âé¶¹Ô´´ Share by Type (2020-2031)
4.2 Global PTA Balloons for Peripheral Arterial Disease Revenue by Type (2020-2031)
4.2.1 Global PTA Balloons for Peripheral Arterial Disease Revenue by Type (2020-2025)
4.2.2 Global PTA Balloons for Peripheral Arterial Disease Revenue by Type (2026-2031)
4.2.3 Global PTA Balloons for Peripheral Arterial Disease Revenue Âé¶¹Ô´´ Share by Type (2020-2031)
4.3 Global PTA Balloons for Peripheral Arterial Disease Price by Type (2020-2031)
5 Segment by Application
5.1 Global PTA Balloons for Peripheral Arterial Disease Sales by Application (2020-2031)
5.1.1 Global PTA Balloons for Peripheral Arterial Disease Sales by Application (2020-2025)
5.1.2 Global PTA Balloons for Peripheral Arterial Disease Sales by Application (2026-2031)
5.1.3 Global PTA Balloons for Peripheral Arterial Disease Sales Âé¶¹Ô´´ Share by Application (2020-2031)
5.2 Global PTA Balloons for Peripheral Arterial Disease Revenue by Application (2020-2031)
5.2.1 Global PTA Balloons for Peripheral Arterial Disease Revenue by Application (2020-2025)
5.2.2 Global PTA Balloons for Peripheral Arterial Disease Revenue by Application (2026-2031)
5.2.3 Global PTA Balloons for Peripheral Arterial Disease Revenue Âé¶¹Ô´´ Share by Application (2020-2031)
5.3 Global PTA Balloons for Peripheral Arterial Disease Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Company Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic PTA Balloons for Peripheral Arterial Disease Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Medtronic PTA Balloons for Peripheral Arterial Disease Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 Boston Scientific
6.2.1 Boston Scientific Company Information
6.2.2 Boston Scientific Description and Business Overview
6.2.3 Boston Scientific PTA Balloons for Peripheral Arterial Disease Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Boston Scientific PTA Balloons for Peripheral Arterial Disease Product Portfolio
6.2.5 Boston Scientific Recent Developments/Updates
6.3 Abbott
6.3.1 Abbott Company Information
6.3.2 Abbott Description and Business Overview
6.3.3 Abbott PTA Balloons for Peripheral Arterial Disease Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Abbott PTA Balloons for Peripheral Arterial Disease Product Portfolio
6.3.5 Abbott Recent Developments/Updates
6.4 COOK
6.4.1 COOK Company Information
6.4.2 COOK Description and Business Overview
6.4.3 COOK PTA Balloons for Peripheral Arterial Disease Sales, Revenue and Gross Margin (2020-2025)
6.4.4 COOK PTA Balloons for Peripheral Arterial Disease Product Portfolio
6.4.5 COOK Recent Developments/Updates
6.5 Cardiovascular Systems
6.5.1 Cardiovascular Systems Company Information
6.5.2 Cardiovascular Systems Description and Business Overview
6.5.3 Cardiovascular Systems PTA Balloons for Peripheral Arterial Disease Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Cardiovascular Systems PTA Balloons for Peripheral Arterial Disease Product Portfolio
6.5.5 Cardiovascular Systems Recent Developments/Updates
6.6 Terumo
6.6.1 Terumo Company Information
6.6.2 Terumo Description and Business Overview
6.6.3 Terumo PTA Balloons for Peripheral Arterial Disease Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Terumo PTA Balloons for Peripheral Arterial Disease Product Portfolio
6.6.5 Terumo Recent Developments/Updates
6.7 B. Braun
6.7.1 B. Braun Company Information
6.7.2 B. Braun Description and Business Overview
6.7.3 B. Braun PTA Balloons for Peripheral Arterial Disease Sales, Revenue and Gross Margin (2020-2025)
6.7.4 B. Braun PTA Balloons for Peripheral Arterial Disease Product Portfolio
6.7.5 B. Braun Recent Developments/Updates
6.8 Biotronik
6.8.1 Biotronik Company Information
6.8.2 Biotronik Description and Business Overview
6.8.3 Biotronik PTA Balloons for Peripheral Arterial Disease Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Biotronik PTA Balloons for Peripheral Arterial Disease Product Portfolio
6.8.5 Biotronik Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 PTA Balloons for Peripheral Arterial Disease Industry Chain Analysis
7.2 PTA Balloons for Peripheral Arterial Disease Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 PTA Balloons for Peripheral Arterial Disease Production Mode & Process Analysis
7.4 PTA Balloons for Peripheral Arterial Disease Sales and Âé¶¹Ô´´ing
7.4.1 PTA Balloons for Peripheral Arterial Disease Sales Channels
7.4.2 PTA Balloons for Peripheral Arterial Disease Distributors
7.5 PTA Balloons for Peripheral Arterial Disease Customer Analysis
8 PTA Balloons for Peripheral Arterial Disease Âé¶¹Ô´´ Dynamics
8.1 PTA Balloons for Peripheral Arterial Disease Industry Trends
8.2 PTA Balloons for Peripheral Arterial Disease Âé¶¹Ô´´ Drivers
8.3 PTA Balloons for Peripheral Arterial Disease Âé¶¹Ô´´ Challenges
8.4 PTA Balloons for Peripheral Arterial Disease Âé¶¹Ô´´ Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Âé¶¹Ô´´ Size Estimation
10.1.3 Âé¶¹Ô´´ Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Medtronic
Boston Scientific
Abbott
COOK
Cardiovascular Systems
Terumo
B. Braun
Biotronik
Ìý
Ìý
*If Applicable.
